Icure Pharmaceutical Incorporation Logo

Icure Pharmaceutical Incorporation

A biopharmaceutical firm specializing in Transdermal Drug Delivery System technology.

175250 | KO

Overview

Corporate Details

ISIN(s):
KR7175250000
LEI:
Country:
South Korea
Address:
서울특별시 강남구 봉은사로104길 10 7층, 강남구

Description

Icure Pharmaceutical Incorporation is a biopharmaceutical company that researches, develops, manufactures, and commercializes high-tech drug products. The company's core expertise lies in its Transdermal Drug Delivery System (TDDS) technology, which facilitates 'Cure & Care' solutions through the skin. Its portfolio includes both pharmaceutical products, such as NSAIDS patches, and cosmetic lines developed with a pharmaceutical and medical foundation. Icure focuses on creating innovative formulations and drug delivery systems to improve therapeutic outcomes and patient convenience.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-05-15 00:00
분기보고서 (2019.03)
Korean 1.4 MB
2019-04-18 00:00
증권발행결과(자율공시)(제2회차)
Korean 5.9 KB
2019-04-18 00:00
증권발행결과(자율공시)(제3회차)
Korean 5.9 KB
2019-04-16 00:00
주요사항보고서(전환사채권발행결정)
Korean 49.6 KB
2019-04-16 00:00
주요사항보고서(전환사채권발행결정)
Korean 38.2 KB
2019-04-09 00:00
기타경영사항(특허권취득)(자율공시)(세포 침투 효과가 우수한 보툴리늄 유래 펩타이드를 포함하는 화장료 조성물)
Korean 5.1 KB
2019-04-05 00:00
타법인주식및출자증권취득결정
Korean 27.3 KB
2019-04-04 00:00
[기재정정]사업보고서 (2018.12)
Korean 1.3 MB
2019-04-01 00:00
사업보고서 (2018.12)
Korean 505.4 KB
2019-03-22 00:00
전환청구권행사
Korean 8.8 KB
2019-03-22 00:00
정기주주총회결과(제19기)
Korean 27.2 KB
2019-03-14 00:00
감사보고서제출
Korean 26.8 KB
2019-03-12 00:00
신규시설투자등
Korean 10.3 KB
2019-03-07 00:00
주식매수선택권부여에관한신고
Korean 13.6 KB
2019-03-07 00:00
주주총회소집결의
Korean 16.0 KB

Automate Your Workflow. Get a real-time feed of all Icure Pharmaceutical Incorporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Icure Pharmaceutical Incorporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Icure Pharmaceutical Incorporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.